Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Is somebody shorting here?
C’mon Mr Woo Kim_ Is this REAL???_ LAS VEGAS, NV--(Marketwired - Jun 8, 2015) - RAMOIL MANAGEMENT, Ltd. (OTC PINK: RAMO) announced today that they have secured a new partnership agreement. RAMO recently finalized a funding and distribution deal with United Enterprises that is integral to the company's ability to sustain long term growth and forecasts the generation of significant near-term revenues.
Company executives have been working diligently to finalize details of the agreement and are excited to announce this new deal. Tim Stokes, CEO of Ramoil Management, Ltd. said, "We are delivering on every pledge we've made to our shareholders and United Enterprises is a big part of that promise," he added, "UE (United Enterprises) is securing our ability to build on our partnership with (organizations like) Nature Elements and this deal will help generate revenues well into the six figures in the near term." United Enterprises is providing funding for CBD extraction equipment and will assist with the distribution of RAMO hydroponic products.
Stokes also commented on future partnerships mentioned in previous shareholder updates. "Today's announcement is a major step on our road to profitability. There are several partnership and consulting agreements we are working on that will allow us to scale our business exponentially." Stokes also alluded to the fact that this new agreement will significantly strengthen existing partnerships and will allow the company greater financial flexibility.
About Ramoil Management, Ltd. Ramoil Management, Ltd. (RAMO) is a development stage company focused on the operations of licensed and legal cultivation, extraction, manufacturing and retail facilities. The company's evolving business plan establishes domestic and international research and production laboratories working to perfect a proprietary strain of high CBD/low THC extraction compounds. The company plan focuses on revenues generated from the delivery of CBD extractions, concentrates and medicines using established wholesale and retail partnerships.
Forward Looking Statements: This news release contains forward-looking statements made by RAMOIL MANAGEMENT, LTD. All such statements included in this press release, other than statements of historical fact, are forward-looking statements. Although management believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Actual results may differ materially from those indicated by these statements. The following risk factors, among others, could cause actual results to differ materially from those described in any forward- looking statements. These risks and uncertainties include, but are not limited to, economic conditions, changes in the law or regulations, demand for products of the Company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward looking statements. Forward-looking statements are typically identified by the words: believe, expect, anticipate, intend, estimate, and similar expressions or which by their nature refer to future events. The Company is not entitled to rely on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 because it is not registered under either Act.
We could be at 2 pennies if there was any MJ news that was compelling!!
But I just don’t see it. What happened to the hub? Is it just going to be ancillary weed products sales? Where’s the numbers on that trumped up, recent purchase order? Is this just a repeat of both, MG, and his old press releases?
How can WOO KIM and any other directors agree to pay a former CEO a million dollars who you say only succeeded in running the stock short term but never made head way in building up the company ???
Woo Kim_LOOKIE HERE_Someone here is making you look more successful than you really are.
IMO, the 30k is just a book entry. . . because salaries are deferred, according to the periodic financial report. . . they aren’t spending 30k on anything. Also, they cannot have accepted delivery of a CO2 machine with no place to put it. . . so they haven't paid anything on that either, IMO. They are really not spending much on their simple disclosures to OTC Markets that they call filings, either.
AIMHO
It's going to take one,Out-of-this-world PR on Monday
Can the new CEO pull this out of the muck & mire?
Woo_ At least give Shareholders a glass of water
so they won't get too sick and die.
Maybe they can verify/identify a source of financing, eh?
Unfortunately, Bucky, the ADVANTIS mj business and any revenues or expectation of revenues can only be described as nebulous---
….hazy, vague, indistinct, or confusing, cloudy.
Woo Kim_ Try to HELP your desperate Shareholders
by giving them some ‘meat of the bone’ before we become mindlessly ill.
I'd like to see some concrete MJ news for a change.
Woo_Your Shareholders are so malnourished on accurate news
they are about to go into convulsions.
Maybe they'll put out a repeat of an old RAMO PR
again like they've been doing.
They haven't gotten any traction with MJ
It appears to be a pump & dump exercise, that's why, IMO. It's been all promises.
Woo – 9 Months later_Your stock is lower
ADVT down (- 46.15%)
I read it in their piecemeal annual report and Q
but if he's a Charlatan, why should he benefit?
So HOW can Goeree legitimately collect money on this?
Bucky - I’m stuck on $ADVT.
I’m a Stuckholder.
What precisely they did there remains a mystery.
It's been 9 months of mostly BS, IMO.
Woo - Shareholder value being blown away. . . .
like the cloud of smoke your team created, IMO.
We’d like to believe noble intentions are more prevalent than corrupt intentions, however, manipulating news was a low blow.
AIMHO
Woo - Your stock isn't sinking. . . .
It's dissipating like a cloud of smoke.
Goeree owed $855,000 and convertible??
Could cannabis freedom be closer than you think? Each of the presidential candidates support some kind of reform
March 31, 2016 - J.D. Heyes
(NaturalNews) When Sen. Marco Rubio, R-Fla., dropped out of the presidential race in recent weeks, that left every other viable candidate supporting at least a state's right to legalize marijuana if its voters chose to do so. And while recreational pot use remains against federal law – something that Congress will need to address lest the next administration be more aggressive about enforcing that law – all of the remaining viable candidates in both parties at least support a state's right to decide on legalization, Rolling Stone magazine reported recently.
The political backing is there, as well; more Americans than ever (58 percent) now believe that pot should be legalized, and many will consider that an important issue heading into November. However, it's not clear whether the presidential candidates' support of legalization will be enough to influence federal policy as well.
As Rolling Stone reported further:
While the actions of Congress and the AG could undermine what the next president is saying today about marijuana policy, the conflict between state and federal law is becoming less tolerable: A whopping 72 percent of Americans believe marijuana law enforcement costs more than it's worth, and 60 percent say federal prohibition laws shouldn't apply in states where cannabis is legal.
"The time is long overdue"
"Candidates from both political parties recognize that advocating for marijuana law reform is a political opportunity, not a political liability," Paul Armentano, deputy director of the National Organization for the Reform of Marijuana Laws, or NORML, told the magazine. Rubio, who has taken substantial "contributions" from the prison–industrial complex, supported the enforcement of federal law in states that have voted to legalize pot use.
Sen. Bernie Sanders, I-Vt., a proud socialist running for the Democrat presidential nomination who recently won one of the states – Washington – that has passed a measure legalizing weed, is the most liberal on marijuana policy. On the campaign trail, Sanders has said he wants to end the oppressive War on Drugs and supports allowing states to legalize pot if they want, as well as de-scheduling it (removing it from the federal Controlled Substances Act).
"In my view, the time is long overdue for us to remove the federal prohibition on marijuana," Sanders said at George Mason University in October. "States should have the right to regulate marijuana the same way that state and local laws now govern the sale of alcohol and tobacco. And among other things, that means that recognized businesses in states that have legalized marijuana should be fully able to use the banking system without fear of federal prosecution."
Hillary Clinton is behind Sanders on the matter of cannabis policy, and has said that she would continue the Obama Administration's enforcement guidelines (which has been to officially support states' rights on the issue while continuing to use taxpayer funds to terrorize marijuana users, producers and distributors). She claims that she supports the states' right to legalize (but not states' rights on other issues, like what does and does not constitute marriage); however, she has also proposed to reschedule, rather than de-schedule, cannabis.
"Medical [marijuana] should happen — right?"
"I think that states are the laboratories of democracy, and four states have already taken action to legalize, and it will be important that other states and the federal government take account of how that's being done, that we learn from what they're doing," Clinton said on WBZ News Radio in January. "I do think on the federal level we need to move marijuana from the Schedule I of drugs, [and] move it to Schedule II, which will permit it to be the basis for medical research."
Rescheduling, Rolling Stone noted, would allow for more scientific research but wouldn't do much to lessen the impact of prohibition.
GOP frontrunner Donald Trump, like Clinton, also believes there should be more cannabis research. And while he has criticized Colorado's law – "bad things happening with people's health" – he says cannabis deserves more study.
"I think medical should happen — right? Don't we agree? I think so. And then I really believe we should leave it up to the states," Trump said during a Nevada campaign event in the fall.
And Sen. Ted Cruz, R-Texas, says he doesn't support legalization but does "support the Constitution" and states' Tenth Amendment right to decide on their own if legalization makes sense for them and their citizens.
Sources:
RollingStone.com
People-Press.org
WashingtonPost.com
http://www.naturalnews.com/z053498_cannabis_freedom_presidential_candidates_drug_law_reform.html
This does add some credibility and I must apologize to Executive Director Woo Kim. VP Broderick kept his promise to shareholders and the ADVANTIS Annual Report was released on a time after all.
Hooray for Hollywood!
ADVANTIS ANNUAL REPORT IS OUT
Director Woo Kim – I’m none too satisfied with the way you embellished your press releases with so many exclamations of “excitement” from you and your management team. IMO, this smacks of a distinctive, promotional slant you have placed on many of the promising statements held out for shareholders by you and the officers of this company in much of your press since July 2015.
In addition, how can you explain what you think you are doing putting out repeats of several old RAMO press releases from months, even years ago, as though they were new to ADVT/RAMO shareholders? …such as including, the repeat purchase of a CO2 extraction machine, repeat announcement of an old MJ partnership/consulting agreement, your claims of delivering of MJ related products and services to that consultant again, or your repeat search for a MJ Distribution Facility? You did not even include any financial details in relation to your latest purchase order announcement, and now, you are late in filing this company’s annual financial report.
AIMHO.
I bought stock in the .008's. That money's gone.
Looked to me that a former insider needed to cash out and was aided & assisted to do so on a BS pump job. Plus some regular shareholders left on their own due to lack of performance, IMO.
Apparently, we needed it Yesterday!
It was a Mutiny today.
Skip the French fries.
We'll take a side of beef..$$$
They Gots to give us some meat-of-the-bone
C'mon Woo - Notification of Late Filing not exactly awe inspiring
.0029 Woo hoo!
When do we get the game-changing part ???
It's called incompetance.
BS promises and no liquidity is the result. They couldn't even file the Annual Report on time.
ADVT +84.62% _ It's a Bonanza
NEURAL IMPRINTING CAN SWITCH OFF PAIN!
Here’s an article/ad that I mentioned that had I read - for anyone that interested.
John Wilkinson
THIS WILL BE HUGE !
DAVID M. ADAM, JR.
4435 N.PERSHING DRIVE #709 ARLINGTON,VIRGINIA 22203 USA
c/o ADD INTERNATIONAL,LLC.-PRES.& CEO
WASHINGTON,D.C.
TEL.# 1-703 2431999
SKYPE:addintlusa
EMAIL:addintlusa@comcast.net
----- Forwarded Message -----
From: "John Wilkinson" <customerservice@moneymappress.com>
To: ADDINTLUSA@comcast.net
Sent: Monday, March 28, 2016 4:35:16 PM
Subject: Full Transcript
Dear Reader,
Thank you for reviewing Michael Robinson's special Neural Imprinting briefing.
For your convenience, I've included a link to the full, text-only transcript below.
Michael's presentation certainly shocked me when I first read it. My first reaction was "no way."
But when I saw and read the details... how this revolutionary new device demonstrated a miraculous ability to eliminate pain... and how Neural Imprinting can switch off pain, anywhere in your body, almost instantly - without dangerous side effects... well, it's one of the most moving and important pieces of analysis I've ever seen.
This is a true paradigm shift in the field of medicine. The most influential companies and investors - including Microsoft and Google - are rushing to fund this revolutionary technology.
This breakthrough can save amputees, cancer patients, and war heroes untold amounts of suffering...
It can also help everyone dealing with common types of pain - from hip replacements and arthritis to minor headaches. Soon these devices will be in every home in America.
Which is why we project these Neural Imprinting devices will create $2.86 trillion in new wealth by 2020.
And one tiny company in the heart of Silicon Valley controls an astronomical number of patents for this technology.
While almost no one in America knows its name right now...
It is already a publicly traded company.
By getting in early, you could profit from their potential 6,642% spike in revenue. That's the equivalent of turning...
* Every $50 you invest into $3,321.
* Every $500 into $33,210.
* And Every $5,000 into $332,100.
The first commercial Neural Imprinting device is scheduled for release in early 2016.
But today we're recruiting 500 readers who want to test a prototype of this type of technology before the first commercial model is released.
This is being done on a first come, first serve basis, so there's no time to waste.
Just go here for full details. This is the full, text-only transcript of Michael Robinson's briefing.
And, as always, if you have any questions about this opportunity, please don't hesitate to call me at 855.509.6600 or 443.353.4770 .
Just be sure to call or get started online today.
Sincerely,
John Wilkinson
Director, VIP Services
Money Morning
Review the Transcript
You are receiving this email as a part of your subscription to Money Map Press.
You will be able to unsubscribe from your first weekly email.
2015 Money Map Press,
Money Map Press | Attn: Member Services | 16 West Madison Street | Baltimore, MD 21201
North America: 1.888.384.8339; International: +1.443.353.4519; Fax: 1.410.622.3050
Contact Customer Service
Website: http://www.moneymappress.com
Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions' they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice.